Scholarlink

Background <p>Breast cancer (BRCA) is substantial risk to human health and life. Studies have shown that PANoptosis and explores relationship between PANoptosis and BRCA patient’s prognosis.</p> Methods <p>The TCGA-BRCA cohort and GSE7390 dataset were analyzed to investigate 19 PANoptosis-related genes (PRGs). Differentially expressed genes (DEGs 1) between BRCA and normal samples were identified, and Weighted Gene Co-expression Network Analysis (WGCNA) was applied to select genes most correlated with the PANoptosis score. Key module genes were intersected with DEGs 1, and candidate genes were determined using Kaplan–Meier analysis, stratifying BRCA samples into high- and low-expression groups. TEX11-related DEGs were further explored. Prognostic candidate genes were screened via univariate Cox and LASSO regression, and final independent prognostic factors were confirmed through univariate and multivariate Cox analyses.</p> Results <p>The 578 intersection genes were acquired via taking intersection of&#xa0;5,044 DEGs 1 and 1,947 key module genes. TEX11 was subsequently selected for further analysis among these. TEX11 expression levels classify&#xa0;BRCA patients into a high and low group. According to GSEA, regulation of <i>T</i> cell-mediated cytotoxicity was concentrated in the TEX11 high group. 14 differential immune cells were identified, and TEX11 was positively relevant to M1 Macrophages. Next, nine immune checkpoints and TIDE scores in high-expression group showed an upward trend. Moreover, 18 drugs were significant differences between two expression groups, such as Gemcitabine. Finally, 5 biomarkers and 3 independent prognostic factors&#xa0;were identified.</p> Conclusion <p>This study established TEX11 as important gene related to prognosis of BRCA, identified five related BRCA biomarkers, highlighted three independent prognostic factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring the prognostic value and biomarker of TEX11 in breast cancer via PANoptosis

  • 期刊论文

  • 发表日期：

    2025年11月3日

查看全文
  • Jiachen Liu,
  • Wenzhe Ma,
  • Haiyan Zhang,
  • Meina Shi,
  • Wanjun Lin,
  • Zifeng Huang,
  • Yanchao Yang

摘要

Background

Breast cancer (BRCA) is substantial risk to human health and life. Studies have shown that PANoptosis and explores relationship between PANoptosis and BRCA patient’s prognosis.

Methods

The TCGA-BRCA cohort and GSE7390 dataset were analyzed to investigate 19 PANoptosis-related genes (PRGs). Differentially expressed genes (DEGs 1) between BRCA and normal samples were identified, and Weighted Gene Co-expression Network Analysis (WGCNA) was applied to select genes most correlated with the PANoptosis score. Key module genes were intersected with DEGs 1, and candidate genes were determined using Kaplan–Meier analysis, stratifying BRCA samples into high- and low-expression groups. TEX11-related DEGs were further explored. Prognostic candidate genes were screened via univariate Cox and LASSO regression, and final independent prognostic factors were confirmed through univariate and multivariate Cox analyses.

Results

The 578 intersection genes were acquired via taking intersection of 5,044 DEGs 1 and 1,947 key module genes. TEX11 was subsequently selected for further analysis among these. TEX11 expression levels classify BRCA patients into a high and low group. According to GSEA, regulation of T cell-mediated cytotoxicity was concentrated in the TEX11 high group. 14 differential immune cells were identified, and TEX11 was positively relevant to M1 Macrophages. Next, nine immune checkpoints and TIDE scores in high-expression group showed an upward trend. Moreover, 18 drugs were significant differences between two expression groups, such as Gemcitabine. Finally, 5 biomarkers and 3 independent prognostic factors were identified.

Conclusion

This study established TEX11 as important gene related to prognosis of BRCA, identified five related BRCA biomarkers, highlighted three independent prognostic factors.